COAG Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States …
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? Board appointment and index inclusion frame Hemab Therapeutics Holdings Hemab Therapeutics Holdings (COAG) has appointed Keli Walbert to its Board and Audit Committee, and the stock has also been added to multiple Russell indices, drawing fresh attention from institutional screens. For Hemab Therapeutics Holdings, the recent HMB-003 trial initiation and a wave of Russell index inclusions have arrived during a choppy period, with the 30-day share price return down 26.14% and the year-to-date... | ||
Biotech IPO Gains Crush AI Listings With Standout 55% Return (Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Cam | ||
Sector Update: Healthcare Stocks Advance Late Afternoon Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and | ||